Niagen Bioscience (NAGE) Capital Expenditures Growth (3y) (2016 - 2026)
Niagen Bioscience (NAGE) Capital Expenditures Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Niagen Bioscience |
280.11 Mn |
213.56 Mn |
19.98 Mn |
-12.48% |
| Date | Value |
|---|
| Mar 31, 2026 |
-12.48% |
| Dec 31, 2025 |
-16.26% |
| Sep 30, 2025 |
-22.72% |
| Jun 30, 2025 |
16.67% |
| Mar 31, 2025 |
8.58% |
| Dec 31, 2024 |
225.54% |
| Sep 30, 2024 |
-24.69% |
| Jun 30, 2024 |
-64.36% |
| Mar 31, 2024 |
-3.76% |
| Dec 31, 2023 |
-57.37% |
| Sep 30, 2023 |
38.38% |
| Jun 30, 2023 |
28.23% |
| Mar 31, 2023 |
100.55% |
| Dec 31, 2022 |
-14.99% |
| Sep 30, 2022 |
-30.52% |
| Jun 30, 2022 |
7.20% |
| Mar 31, 2022 |
-52.88% |
| Dec 31, 2021 |
-41.52% |
| Sep 30, 2021 |
37.41% |
| Jun 30, 2021 |
-38.02% |
